The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hogge Gary S. since 2021.
This trader's CIK number is 1771711.
At the time of last reporting, Hogge Gary S. was the SVP,Clinical & Medical Affairs of Lineage Cell Therapeutics, Inc.. (stock ticker symbol LCTX).
Also see all insider trading activities at Lineage Cell Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | LCTX | 0 | $0 | 0 | $0 | 13,020 | $0 |
| 2021 | LCTX | 0 | $0 | 539,283 | $1,321,808 | 510,838 | $665,486 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-11 | LCTX | Option Ex | 13,020 | .00 | 0 |
| 2021-12-29 | LCTX | Sale | 37,695 | 2.46 | 92,918 |
| 2021-12-28 | LCTX | Sale | 501,588 | 2.45 | 1,228,890 |
| 2021-12-29 | LCTX | Option Ex | 9,250 | .69 | 6,400 |
| 2021-12-28 | LCTX | Option Ex | 501,588 | 1.31 | 659,086 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hogge Gary S. (SVP,Clinical & Medical Affairs of Lineage Cell Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.